Nanomaterials (Dec 2022)

CeO<sub>2</sub>-Azacrown Conjugate as a Nanoplatform for Combined Radiopharmaceuticals

  • Sofia Khabirova,
  • Gleb Aleshin,
  • Tatiana Plakhova,
  • Anastasia Zubenko,
  • Anna Shchukina,
  • Olga Fedorova,
  • Aleksey Averin,
  • Ekaterina Belova,
  • Elena Bazarkina,
  • Kristina Kvashnina,
  • Stepan Kalmykov

DOI
https://doi.org/10.3390/nano12244484
Journal volume & issue
Vol. 12, no. 24
p. 4484

Abstract

Read online

This study is one of the first attempts to assess CeO2 nanoparticles as a nanoplatform for radiopharmaceuticals with radionuclides. The process of functionalization using a bifunctional azacrown ligand is described, and the resulting conjugates are characterized by IR and Raman spectroscopy. Their complexes with 207Bi show a high stability in medically relevant media, thus encouraging the further study of these conjugates in vivo as potential combined radiopharmaceuticals.

Keywords